| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 08/08/2002 | WO2002060436A2 Use of fredericamycin a and its derivatives in the treatment of pin1-associated states |
| 08/08/2002 | WO2002024650A3 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 08/08/2002 | US20020107395 Reacting cyclohexanone with ethylcyanoacetate in the presence of ammonium hydroxide to form alpha, alpha'-dicyano-beta, beta-pentamethyleneglutarimide |
| 08/08/2002 | CA2432981A1 Use of fredericamycin a and its derivatives in the treatment of pin1-associated states |
| 08/07/2002 | CN1088697C Sterically hindered-4-amino-piperidine with low dimer content, its preparation method and use |
| 08/06/2002 | US6428667 Multichromophore fluorescent probes using DNA intercalation complexes |
| 08/06/2002 | CA2231812C Cyclic nitrones and pharmaceutical compositions containing them |
| 08/01/2002 | WO2002059124A2 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 08/01/2002 | WO2002059082A2 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 08/01/2002 | WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 08/01/2002 | US20020103169 Use of anticancer agents of the phenanthridine class having a specific mechanism of action and cancer therapy |
| 08/01/2002 | CA2432122A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 08/01/2002 | CA2431904A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 07/31/2002 | EP1226121A1 Method of inhibiting neurotrophin-receptor binding |
| 07/31/2002 | CN1088359C Medicine for curing cerebrovascular disturbance with psychonosema |
| 07/30/2002 | US6426415 Polyadenosine 5'-diphospho-ribose polymerase (parp) enzyme inhibitors, alkoxy substituted n-heterocycle derivatives |
| 07/30/2002 | US6426352 Inhibit the farnesylation of the oncogene protein ras; (+)-4-(3-bromo-8,10-dichloro-6,11-dihydro-5h-benzo(5,6)-cyclohepta(1,2 -b)pyridin-11-yl)-1-(methylsulfonyl)piperidine, for example |
| 07/30/2002 | CA2078039C Process for the production of lactams |
| 07/30/2002 | CA2056619C Method of inactivation of viral and bacterial blood contaminants |
| 07/25/2002 | WO2002056887A1 New combination of active ingredients containing alfuzosine and apomorphine |
| 07/25/2002 | WO2002056875A2 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance |
| 07/25/2002 | WO2002039879A3 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 07/25/2002 | WO2002032901A3 Bridged piperazine derivatives |
| 07/25/2002 | US20020099084 Pharmaceutically active compounds and methods of use |
| 07/25/2002 | US20020099048 Bicycloloactam compounds, use thereof and intermediates for preparing thereof |
| 07/25/2002 | CA2434736A1 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance |
| 07/24/2002 | EP1224933A1 New combination of active ingredients containing alfuzosine and apomorphine |
| 07/24/2002 | EP1223921A2 Tissue factor antagonists and methods of use thereof |
| 07/24/2002 | EP0900218B1 Heterocyclic compounds |
| 07/24/2002 | EP0885230B1 Camptothecin derivatives and the use thereof as antitumor agents |
| 07/24/2002 | EP0804431B1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 07/24/2002 | CN1360588A Hemisynthetic method and intermediate thereof |
| 07/23/2002 | US6423842 Act preferentially on m4 receptors; side effect reduction; used to treat nervous system disorders, psychological disorders and as an analgesic; alzheimer's disease; cognition activators. |
| 07/18/2002 | US20020095029 Nucleic acid bulge-detecting agent |
| 07/16/2002 | US6420390 Heteroarylpiperidines and their use as antipsychotics |
| 07/11/2002 | WO2002053543A1 Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 07/11/2002 | WO2002053528A1 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 07/11/2002 | WO2001096311A3 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 07/11/2002 | US20020091273 Method for the regioselective preparation of substituted benzo[g]quinoline3-carbonitriles and benzo[g]quinazolines |
| 07/11/2002 | CA2431679A1 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 07/10/2002 | EP1221439A1 Tetrahydroquinoline derivatives |
| 07/10/2002 | EP1220849A2 Bicyclic compounds composition and method for stabilizing the same |
| 07/09/2002 | US6416735 Ligands for α-7 nicotinic acetylcholine receptors based on methyllcaconitine |
| 07/04/2002 | WO2002051924A1 Preparation of dyed plastics or polymeric dye particles |
| 07/04/2002 | WO2002051416A1 Drugs for improving ability of daily life behaviors in alzheimer's disease |
| 07/04/2002 | WO2000075116A3 Tricyclic analgesics |
| 07/04/2002 | US20020086999 Certain quinoline derivatives |
| 07/04/2002 | US20020086887 N-Acylsulfonamide apoptosis promoters |
| 07/04/2002 | CA2430604A1 Preparation of dyed plastics or polymeric dye particles |
| 07/03/2002 | CN1356984A Neurotrophin protentiators |
| 06/26/2002 | CN1086698C Oxadizoles, processes for their preparation and their use as medicaments |
| 06/25/2002 | US6410791 Salbutamol; respiratory system disorders |
| 06/25/2002 | US6410561 Analgesics |
| 06/25/2002 | US6410551 Bronchodilator |
| 06/25/2002 | US6410550 Aryl fused azapolycyclic compounds |
| 06/25/2002 | US6410526 Bone disorders; restenosis; vision disorders; anticholesterol agents; anticancer, antitumor agents |
| 06/25/2002 | US6410505 Dimeric non-azo naphthalimides and uses for the same |
| 06/20/2002 | US20020077331 Synthesis of intermediates useful in preparing tricyclic compounds |
| 06/20/2002 | US20020076648 Optical data medium containing, in the information layer, a phthalocyanine dye as a light-absorbing compound |
| 06/19/2002 | EP1214318A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 06/19/2002 | EP1213967A1 Antimicrobial polymer |
| 06/19/2002 | CN1354751A Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging |
| 06/18/2002 | US6407108 1,2,4-triazolo(4,3-b)pyrido(3,2-d)pyridazine derivatives and pharmaceutical compositions containing them |
| 06/13/2002 | WO2002030906B1 Anti-tumour compounds |
| 06/13/2002 | US20020072528 Are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit T-helper-type 2 immune response; useful for therapy of viral and neoplastic diseases |
| 06/13/2002 | US20020072525 Aryl fused azapolycyclic compounds |
| 06/13/2002 | US20020072524 Aryl fused azapolycyclic compounds |
| 06/12/2002 | EP0885204B1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 06/12/2002 | EP0460062B1 Huperzine a analogs |
| 06/12/2002 | CN1353715A Naphthopyrans annelated in C5-C6 with alactam-type C6 ring and compositions and (CO) polymer containing them |
| 06/12/2002 | CN1086188C Novel phenanethridinium derivatives |
| 06/11/2002 | US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and |
| 06/11/2002 | US6403583 Anticoagulant agents for treatment and prevention of thromboembolic disorders. |
| 06/06/2002 | WO2002044416A2 Sulfonated diarylrhodamine dyes as fluorescent labels |
| 06/06/2002 | WO2001068071A3 Use of natural chrysanthone compounds having antiangiogenic activity |
| 06/06/2002 | US20020068742 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 06/06/2002 | CA2429816A1 Sulfonated diarylrhodamine dyes as fluorescent labels |
| 06/05/2002 | EP1210333A2 Novel herbicides |
| 06/05/2002 | EP0971920B1 Compounds for inhibition of gastric acid secretion |
| 06/05/2002 | EP0934319B1 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS |
| 06/05/2002 | EP0721942B1 Tetracyclic compound |
| 06/04/2002 | USRE37729 Useful as antipsychotic and analgesic agents. |
| 06/04/2002 | US6399780 Kinase inhibitors; anticancer agents |
| 06/04/2002 | US6399774 Compounds having activity as inhibitors of cytochrome P450RAI |
| 06/04/2002 | CA2029497C 4-acylaminopyridine derivative |
| 05/30/2002 | WO2002043449A1 Luminescent element material and luminescent element comprising the same |
| 05/30/2002 | WO2002020526A3 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 05/29/2002 | EP1149081A4 Aryloxy-poly(oxyalkylene) naphthalimide derivative colorants |
| 05/29/2002 | EP0991637B1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors |
| 05/29/2002 | EP0837851B1 Fluorinated phenanthrene derivatives and their use in liquid crystal mixtures |
| 05/29/2002 | DE10038672A1 New perylene tricarboxylic acid imide derivatives, useful as fluorescence dyes for dyeing natural and synthetic materials |
| 05/29/2002 | CN1085666C 6-aryl pyrido (2,3-d) pyrimidines and naphthyridines for inhibiting protein tyro sine kinase medicated cellular proliferation |
| 05/28/2002 | US6395749 Carboxamide compounds, methods, and compositions for inhibiting PARP activity |
| 05/28/2002 | CA2203618C New metalloprotease inhibitors, their preparation process and the pharmaceutical compounds that contain them |
| 05/23/2002 | WO2002039879A2 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 05/23/2002 | WO2001072707A3 Carbamate caspase inhibitors and uses thereof |
| 05/23/2002 | US20020061913 Bicyclic amine derivatives |
| 05/23/2002 | US20020061901 HMG-CoA reductase inhibitors and method |
| 05/23/2002 | US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis |
| 05/23/2002 | CA2429047A1 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |